ImmuneWatch
Eenmeilaan 52
3010 Kessel-Lo
BE
ImmuneWatch
Foundation date
21/09/2021
Sector
#Biotechnology / R&D ServicesSubsector
- #Therapeutics - Biosimilars
- #Therapeutics - Proteins
- #Therapeutics - Small molecules
- #R&D Services - Analytical services
- #R&D Services - Bioinformatics
- #R&D Services - CRO (Contract Research Organization)
- #R&D Services - Diagnostic services
- #R&D Services - Genomics
- #R&D Services - Screening
- #Pharma - Nucleic acid drugs
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
- #Symptoms - signs and abnormal clinical and laboratory findings - not elsewhere classified
At ImmuneWatch we want to accelerate the development of T-cell based diagnostic tools and therapies. Our mission is to make immune repertoire data interpretable and actionable by annotating T-cell receptors in a clinically meaningful way.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
News by ImmuneWatch
More news-
ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines
Wednesday March 29th 2023
Read more
-
ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI
Monday March 27th 2023
Read more
-
ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers
Monday September 12th 2022
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Contact us
Ellen Telleir
Communication Coordinator